Metabolic Disease Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: M0416F4303A0EN
Market Monitor Global

Abstracts

Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

This report contains market size and forecasts of Metabolic Disease Therapeutics in Global, including the following market information:

Global Metabolic Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Metabolic Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Glycogen Metabolism Disease Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metabolic Disease Therapeutics include Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin and LG Life Science and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabolic Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metabolic Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metabolic Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Glycogen Metabolism Disease Drug
• Lipid Metabolism Disease Drug
• Amino Acid Metabolism Drug
• Other

Global Metabolic Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metabolic Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy

Global Metabolic Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metabolic Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Metabolic Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Metabolic Disease Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Novartis
• Takeda Pharmaceutical
• Astra Zeneca
• Beohrigher Ingelheim
• KOWA
• Kythera
• Fuji yakuhin
• LG Life Science
• Metsubishi Tanabe Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Metabolic Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Metabolic Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL METABOLIC DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Metabolic Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Metabolic Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Metabolic Disease Therapeutics Players in Global Market
3.2 Top Global Metabolic Disease Therapeutics Companies Ranked by Revenue
3.3 Global Metabolic Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Metabolic Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metabolic Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metabolic Disease Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Metabolic Disease Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Metabolic Disease Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Metabolic Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Glycogen Metabolism Disease Drug
  4.1.3 Lipid Metabolism Disease Drug
  4.1.4 Amino Acid Metabolism Drug
  4.1.5 Other
4.2 By Type - Global Metabolic Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Metabolic Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Metabolic Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Metabolic Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
5.2 By Application - Global Metabolic Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Metabolic Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Metabolic Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Metabolic Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Metabolic Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Metabolic Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Metabolic Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Metabolic Disease Therapeutics Revenue, 2017-2028
  6.3.2 US Metabolic Disease Therapeutics Market Size, 2017-2028
  6.3.3 Canada Metabolic Disease Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Metabolic Disease Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Metabolic Disease Therapeutics Revenue, 2017-2028
  6.4.2 Germany Metabolic Disease Therapeutics Market Size, 2017-2028
  6.4.3 France Metabolic Disease Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Metabolic Disease Therapeutics Market Size, 2017-2028
  6.4.5 Italy Metabolic Disease Therapeutics Market Size, 2017-2028
  6.4.6 Russia Metabolic Disease Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Metabolic Disease Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Metabolic Disease Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Metabolic Disease Therapeutics Revenue, 2017-2028
  6.5.2 China Metabolic Disease Therapeutics Market Size, 2017-2028
  6.5.3 Japan Metabolic Disease Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Metabolic Disease Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Metabolic Disease Therapeutics Market Size, 2017-2028
  6.5.6 India Metabolic Disease Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Metabolic Disease Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Metabolic Disease Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Metabolic Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Metabolic Disease Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Metabolic Disease Therapeutics Market Size, 2017-2028
  6.7.3 Israel Metabolic Disease Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Metabolic Disease Therapeutics Market Size, 2017-2028
  6.7.5 UAE Metabolic Disease Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Metabolic Disease Therapeutics Major Product Offerings
  7.1.4 Merck Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Metabolic Disease Therapeutics Major Product Offerings
  7.2.4 Novartis Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Takeda Pharmaceutical
  7.3.1 Takeda Pharmaceutical Corporate Summary
  7.3.2 Takeda Pharmaceutical Business Overview
  7.3.3 Takeda Pharmaceutical Metabolic Disease Therapeutics Major Product Offerings
  7.3.4 Takeda Pharmaceutical Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Takeda Pharmaceutical Key News
7.4 Astra Zeneca
  7.4.1 Astra Zeneca Corporate Summary
  7.4.2 Astra Zeneca Business Overview
  7.4.3 Astra Zeneca Metabolic Disease Therapeutics Major Product Offerings
  7.4.4 Astra Zeneca Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Astra Zeneca Key News
7.5 Beohrigher Ingelheim
  7.5.1 Beohrigher Ingelheim Corporate Summary
  7.5.2 Beohrigher Ingelheim Business Overview
  7.5.3 Beohrigher Ingelheim Metabolic Disease Therapeutics Major Product Offerings
  7.5.4 Beohrigher Ingelheim Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Beohrigher Ingelheim Key News
7.6 KOWA
  7.6.1 KOWA Corporate Summary
  7.6.2 KOWA Business Overview
  7.6.3 KOWA Metabolic Disease Therapeutics Major Product Offerings
  7.6.4 KOWA Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 KOWA Key News
7.7 Kythera
  7.7.1 Kythera Corporate Summary
  7.7.2 Kythera Business Overview
  7.7.3 Kythera Metabolic Disease Therapeutics Major Product Offerings
  7.7.4 Kythera Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Kythera Key News
7.8 Fuji yakuhin
  7.8.1 Fuji yakuhin Corporate Summary
  7.8.2 Fuji yakuhin Business Overview
  7.8.3 Fuji yakuhin Metabolic Disease Therapeutics Major Product Offerings
  7.8.4 Fuji yakuhin Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Fuji yakuhin Key News
7.9 LG Life Science
  7.9.1 LG Life Science Corporate Summary
  7.9.2 LG Life Science Business Overview
  7.9.3 LG Life Science Metabolic Disease Therapeutics Major Product Offerings
  7.9.4 LG Life Science Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 LG Life Science Key News
7.10 Metsubishi Tanabe Pharma
  7.10.1 Metsubishi Tanabe Pharma Corporate Summary
  7.10.2 Metsubishi Tanabe Pharma Business Overview
  7.10.3 Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Major Product Offerings
  7.10.4 Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Metsubishi Tanabe Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Metabolic Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Metabolic Disease Therapeutics Market Drivers in Global Market
Table 3. Metabolic Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Metabolic Disease Therapeutics in Global Market
Table 5. Top Metabolic Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metabolic Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metabolic Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metabolic Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Metabolic Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metabolic Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metabolic Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metabolic Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metabolic Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Metabolic Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metabolic Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metabolic Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Metabolic Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metabolic Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metabolic Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metabolic Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metabolic Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metabolic Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metabolic Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metabolic Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Metabolic Disease Therapeutics Product Offerings
Table 32. Merck Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Metabolic Disease Therapeutics Product Offerings
Table 35. Novartis Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Pharmaceutical Corporate Summary
Table 37. Takeda Pharmaceutical Metabolic Disease Therapeutics Product Offerings
Table 38. Takeda Pharmaceutical Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Astra Zeneca Corporate Summary
Table 40. Astra Zeneca Metabolic Disease Therapeutics Product Offerings
Table 41. Astra Zeneca Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Beohrigher Ingelheim Corporate Summary
Table 43. Beohrigher Ingelheim Metabolic Disease Therapeutics Product Offerings
Table 44. Beohrigher Ingelheim Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. KOWA Corporate Summary
Table 46. KOWA Metabolic Disease Therapeutics Product Offerings
Table 47. KOWA Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Kythera Corporate Summary
Table 49. Kythera Metabolic Disease Therapeutics Product Offerings
Table 50. Kythera Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Fuji yakuhin Corporate Summary
Table 52. Fuji yakuhin Metabolic Disease Therapeutics Product Offerings
Table 53. Fuji yakuhin Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. LG Life Science Corporate Summary
Table 55. LG Life Science Metabolic Disease Therapeutics Product Offerings
Table 56. LG Life Science Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Metsubishi Tanabe Pharma Corporate Summary
Table 58. Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Product Offerings
Table 59. Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Metabolic Disease Therapeutics Segment by Type in 2021
Figure 2. Metabolic Disease Therapeutics Segment by Application in 2021
Figure 3. Global Metabolic Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metabolic Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metabolic Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metabolic Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metabolic Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Pharmaceutical Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astra Zeneca Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Beohrigher Ingelheim Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. KOWA Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Kythera Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Fuji yakuhin Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. LG Life Science Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)